Last updated: November 1, 2023
Sponsor: CinPhloro Pharma, LLC
Overall Status: Active - Recruiting
Phase
2
Condition
Chronic Diarrhea
Irritable Bowel Syndrome (Ibs)
Recurrent Diarrhea
Treatment
N/AClinical Study ID
TX322038
CIN-103-121
Ages 18-90 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Must be at least 18 years old male or female.
- BMI between 18.0 and 40.0
- Have IBS-D for at least 3 months.
- Not have diagnosis of IBS-C
- Not have history of abdominal surgery within the last 3 months before screening
Study Design
Study Start date:
Estimated Completion Date:
Study Description
Connect with a study center
Elite Clinical Studies, LLC
Phoenix, Arizona 85018
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.